AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3124604
Drug: Sucralfate 1
RxNorm normalized name: sucralfate 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate 1 g
Trial: 15886380
Drug: 250 mg/d
RxNorm normalized name: alpelisib 250 mg/day (200 mg x 1 and 50 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg/d of DG-031
Trial: 9792571
Drug: Nebulized budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Nebulized budesonide (1, 2, and 4 mg/d)
Trial: 8704419
Drug: Nourishing the
RxNorm normalized name: Lantiseptic Nourishing Skin
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nourishing the Liver treatment
Trial: 10977438
Drug: Oral levofloxacin
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral levofloxacin
Trial: 22381427
Drug: Trimetazidine (TMZ)
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (TMZ) treatment
Trial: 26848792
Drug: 4-week dose
RxNorm normalized name: milnacipran
DrugBank: Milnacipran (DB04896)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-week dose reduction group
Trial: 26215396
Drug: Normal protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal protein (NP) diet (2 g · kg(‐1) · d(‐1))
Trial: 19020157
Drug: Tapentadol HCl
RxNorm normalized name: tapentadol HCl
DrugBank: Tapentadol (DB06204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tapentadol HCl 75 mg
Trial: 9087161
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide nasal aerosol (220 micrograms, once daily for 6 weeks)
Trial: 2868173
Drug: Antibiotic regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic regimens for preventing or treating wound sepsis
Trial: 8765813
Drug: Nebulized budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Nebulized budesonide (1 mg)
Trial: 22427678
Drug: Highly active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly active antiretroviral therapy (HAART)
Trial: 24315907
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg morphine intravenously
Trial: 17393189
Drug: Oral cryotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cryotherapy (in autologous setting)
Trial: 11125386
Drug: Periurethral autologous
RxNorm normalized name: Autologous cultured fibroblasts
DrugBank: Azficel-T (DB11051)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periurethral autologous fat injection
Trial: 24649785
Drug: Theophylline 250
RxNorm normalized name: theophylline 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline 250 mg three times per day
Trial: 22612662
Drug: Oxytocin infusion
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin infusion (20 IU in 500 mL)
Trial: 28723852
Drug: Skin barrier
RxNorm normalized name: Skin Barrier
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skin barrier cream
Trial: 22751603
Drug: golimumab 100
RxNorm normalized name: golimumab 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: golimumab 100 mg
Trial: 25011986
Drug: Teriparatide (TPTD)
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Teriparatide (TPTD) treatment
Trial: 27894373
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 2 g/day for 24 weeks
Trial: 24375837
Drug: PPI treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPI treatment (14 days enteral omeprazole)
Trial: 20181679
Drug: Combined aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined aspirin (25 mg BID) and extended-release dipyridamole (200 mg BID)
Trial: 1104411
Drug: Placebo or
RxNorm normalized name: placebo ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo or azathioprine 100 mg daily (Control)
Trial: 1104411
Drug: Prednisone in
RxNorm normalized name: Prednisone Intensol
DrugBank: Prednisone (DB00635)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone in doses given on alternate days and titrated (Pred‐Titrad)
Trial: 9663358
Drug: Hylan G-F
RxNorm normalized name: hylan G-F 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hylan G-F 20
Trial: 19263664
Drug: Oral washing
RxNorm normalized name: Zencia Wash
DrugBank: Octasulfur (DB09353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral washing gel
Trial: 8343782
Drug: Topical gel
RxNorm normalized name: Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical gel ultrasound
Trial: 3554085
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy (MeCCNU + 5‐FU) + Levamisole
Trial: 14641610
Drug: Theophylline 10
RxNorm normalized name: theophylline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline 10 mg/kg bodyweight
Trial: 10377504
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment for up to 42 months
Trial: 22042247
Drug: 50-μg SS
RxNorm normalized name: sennosides, USP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50-μg SS (scarification of the skin)
Trial: 2725453
Drug: Zopiclone 7.5
RxNorm normalized name: zopiclone 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone 7.5 mg
Trial: 11841194
Drug: Cleocin T
RxNorm normalized name: Cleocin T
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cleocin T (slightly different gel formulation), indicated for twice-daily use
Trial: 30653147
Drug: Pre-administration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-administration of remifentanil (Group R)
Trial: 20501682
Drug: T4 replacement
RxNorm normalized name: T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: T4 replacement therapy
Trial: 27052635
Drug: Metformin (MET)
RxNorm normalized name: metformin / pioglitazone Oral Tablet [Actoplus Met]
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin (MET) for 52 weeks
Trial: 10434232
Drug: Clindamycin phosphate
RxNorm normalized name: Clindamycin Phosphate
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clindamycin phosphate vaginal cream
Trial: 19273709
Drug: Weekly bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly bolus irinotecan, FU, and leucovorin (IFL)
Trial: 19273709
Drug: Weekly bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly bolus fluorouracil and leucovorin (FU/LV)
Trial: 9563888
Drug: Capecitabine administered
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine administered after fasting
Trial: 9563888
Drug: Capecitabine administered
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine administered after food
Trial: 28682676
Drug: Low-Level Laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Level Laser Therapy (LLLT) (635 nm)
Trial: 23695657
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg Lutein, 1 mg Zeaxanthin, 100 mg DHA, 30 mg EPA, antioxidants (D1)
Trial: 19411393
Drug: Etanercept 25
RxNorm normalized name: etanercept 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 25 mg twice weekly
Trial: 16968715
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg once weekly and 25 mg twice weekly
Trial: 20081039
Drug: Gabapentin 600
RxNorm normalized name: gabapentin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 600 mg three times per day
Trial: 15636035
Drug: Parecoxib preoperatively
RxNorm normalized name: parecoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Parecoxib preoperatively (40 mg IM/IV)
Trial: 15636035
Drug: Parecoxib postoperatively
RxNorm normalized name: parecoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Parecoxib postoperatively (40 mg IM/IV)
Trial: 11102257
Drug: Low-dose subsegments
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose subsegments (<6 Gy)
Trial: 23210383
Drug: 16-week Matrix
RxNorm normalized name: Matrix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16-week Matrix treatment
Trial: 24608864
Drug: Tablet-PC education
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet-PC education
Trial: 28027282
Drug: Rifampin pretreatment
RxNorm normalized name: Rifampin
DrugBank: Rifampin (DB01045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin pretreatment (20 mg/kg) with ceftriaxone
Trial: 1642879
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (vinblastine, mitomycin, cisplatin, and bleomycin) and radiotherapy
Trial: 1642879
Drug: Concomitant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant chemotherapy (cisplatin and bleomycin) and radiotherapy
Trial: 2991689
Drug: ACTH4-9 analog
RxNorm normalized name: insulin glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: ACTH4-9 analog (Org2766) 40 mg/day
Trial: 17244834
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group with contextualized intervention strategy (reinforced counseling, improved communication, decentralization of treatment, choice of DOT supporter, reinforcement of supervision activities)
Trial: 2905252
Drug: Roxatidine acetate
RxNorm normalized name: roxatidine acetate
DrugBank: Roxatidine acetate (DB08806)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxatidine acetate 75 mg twice daily
Trial: 2908751
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg post cenam nocte
Trial: 30202872
Drug: Intensive MDA
RxNorm normalized name: BK-MDA
DrugBank: BK-MDA (DB12809)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive MDA (quarterly single-dose praziquantel plus albendazole daily for 3 days)
Trial: 27825272
Drug: Purified urinary
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified urinary FSH starting with a dose of 75 IU
Trial: 9095564
Drug: One 20
RxNorm normalized name: DIMETHICONE 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One 20 mg controlled-release oxycodone tablet
Trial: 27159505
Drug: Rifapentine (approximately
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifapentine (approximately 7.5 mg/kg) plus moxifloxacin
Trial: 8759069
Drug: Poloxamer 188
RxNorm normalized name: POLOXAMER 188
DrugBank: Poloxamer 188 (DB11333)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Poloxamer 188 (RheothRx) infusion for 48 hours
Trial: 1759572
Drug: Defibrinogenation (DF)
RxNorm normalized name: DF-1001
DrugBank: DF-1001 (DB18231)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Defibrinogenation (DF) therapy
Trial: 27170466
Drug: Estradiol (1
RxNorm normalized name: fluoroestradiol (18F)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol (1 mg/day)
Trial: 27198187
Drug: Medium mycoprotein
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium mycoprotein (88 g)
Trial: 27198187
Drug: High mycoprotein
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High mycoprotein (132 g)
Trial: 11695209
Drug: Colgate Winterfresh
RxNorm normalized name: Colgate
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colgate Winterfresh Gel
Trial: 29038320
Drug: 4CMenB vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4CMenB vaccine (booster dose at 4 years of age)
Trial: 22739141
Drug: Enoxaparin sodium
RxNorm normalized name: Enoxaparin Sodium
DrugBank: Enoxaparin (DB01225)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enoxaparin sodium (1 mg/kg)
Trial: 15665549
Drug: Pentoxifylline (PTX)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PTX) 400 mg three times a day for 2 months
Trial: 326301
Drug: Topical atenolol
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical atenolol (1%, 2%, and 4%)
Trial: 25149179
Drug: Prednisone (PN)
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone (PN) 25 mg
Trial: 25149179
Drug: Methylprednisolone (MPONE)
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (MPONE) 20 mg
Trial: 15881479
Drug: Gatifloxacin 0.3%
RxNorm normalized name: GATIFLOXACIN 0.3% SOLN,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gatifloxacin 0.3% ophthalmic solution
Trial: 1680266
Drug: Midazolam 4-5
RxNorm normalized name: midazolam 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 4-5 mg, intramuscularly
Trial: 18460563
Drug: GH infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GH infusion (45 ng/kg.min, 5.5 h)
Trial: 17070267
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg nociceptin/orphanin FQ in 10 cc saline
Trial: 2660992
Drug: SR IS-5-MN
RxNorm normalized name: IS 5-MN
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SR IS-5-MN 50 mg
Trial: 21959822
Drug: Garlic (KWAI)
DrugBank: Garlic (DB10532)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic (KWAI) 300 mg thrice daily + Metformin 500 mg twice daily
Trial: 26551263
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of velpatasvir once daily
Trial: 1928883
Drug: Hyperbaric treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric treatment (simulated descent of 1,432 m (4,600 ft) in a hyperbaric chamber pressurized to 120 mm Hg (2.3 PSI) above ambient pressure)
Trial: 24721334
Drug: Functional rehabilitation
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional rehabilitation (control; n=20) intervention practicing the same daily tasks with a therapist's demonstration and guidance
Trial: 14687523
Drug: Jing Wan
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jing Wan Hong ointment
Trial: 6762247
Drug: Intrapleural BCG
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrapleural BCG plus oral isoniazid (INH)
Trial: 18544981
Drug: Radiation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation with hormones
Trial: 16340187
Drug: Diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 10 mg by rectiole, followed by 10 mg tablets twice daily for 3 days
Trial: 11463010
Drug: Incidence of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incidence of recurrence after discontinuation of treatment
Trial: 31525422
Drug: Porcine small
RxNorm normalized name: porcine small intestine mucosa lymph follicle preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Porcine small intestine submucosa patch
Trial: 8906519
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg cilazapril
Trial: 7903137
Drug: Transfusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transfusion of whole blood tested negative for HIV antibodies
Trial: 12867218
Drug: IM haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IM haloperidol 7.5 mg
Trial: 22691922
Drug: Lipid-based nutrient
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-based nutrient supplement (LNS) 43 g daily for 12 weeks
Trial: 19906761
Drug: Docetaxel 75
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 75 mg/m² plus Epirubicin 75 mg/m² (DE)
Trial: 28411872
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg risankizumab
Trial: 19335746
Drug: ET receptor
RxNorm normalized name: P2Y12 G-protein-coupled platelet receptor antagonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ET receptor antagonists (ETRAs)
Trial: 18649561
Drug: Fluoride gel
RxNorm normalized name: Sodium Fluoride Gel
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride gel
Trial: 9602960
Drug: Bromfenac sodium
RxNorm normalized name: Bromfenac Sodium
DrugBank: Bromfenac (DB00963)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bromfenac sodium (25 mg)
Trial: 9602960
Drug: Bromfenac sodium
RxNorm normalized name: Bromfenac Sodium
DrugBank: Bromfenac (DB00963)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bromfenac sodium (50 mg)
Trial: 20128823
Drug: Montelukast 10
RxNorm normalized name: montelukast 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 10 mg once daily
Trial: 8494650
Drug: New formulation
RxNorm normalized name: TRIPROLIDINE HYDROCHLORIDE 1.25 mg in 1 mL ORAL SYRUP [HISTEX PD Drops New Formulation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New formulation of almagate (1.5 g, po)
Trial: 25135124
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg of oral melatonin
Trial: 22007026
Drug: Multifactorial treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multifactorial treatment (lifestyle and drug, including atorvastatin)
Trial: 10522578
Drug: mepivacaine 1%
RxNorm normalized name: mepivacaine 1% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mepivacaine 1% with 10 ml saline
Trial: 31407629
Drug: T4 treatment
RxNorm normalized name: T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: T4 treatment
Trial: 23904282
Drug: Leptin administration
RxNorm normalized name: leptin
DrugBank: Leptin (DB05098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leptin administration
Trial: 21513078
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with tidal volume of 10 ml kg(‐1).
Trial: 8862681
Drug: Intraperitoneal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal administration of cisplatin
Trial: 1712735
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of 5,000 IU hCG
Trial: 1712735
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 5,000 IU hCG
Trial: 9243350
Drug: Cyclosporin G
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin G (CSG)
Trial: 22424025
Drug: Dalcetrapib 900
RxNorm normalized name: Dalcetrapib
DrugBank: Dalcetrapib (DB12181)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalcetrapib 900 mg
Trial: 16427490
Drug: Epidural injection
RxNorm normalized name: Sufentanil Citrate 50 ug in 1 mL EPIDURAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural injection of 80 mg methylprednisolone acetate and 10 mg bupivacaine
Trial: 8482993
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (control group)
Trial: 18043999
Drug: Nisoldipine 10
RxNorm normalized name: nisoldipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine 10 mg
Trial: 25517204
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg mirtazapine daily for 8 weeks
Trial: 29690736
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (conventional treatment)